Microbiome Lower Immunotherapy Dose Boosts Response by 30% in Melanoma PatientsBy adminDecember 8, 20250 Credit: Callista Images/Getty Images Researchers in Sweden have found that a lower dose of a common immunotherapy drug for malignant…
Gut Health Lymph node environment drives FSP1 targetability in metastasizing melanomaBy adminNovember 6, 20250 Cell linesB16-F0 (ATCC; CRL-6322) and its LN metastatic derivatives: NBF0-LN1-18IL, NBF0-LN7-1112AR, NBF0-LN7-1120BL, NBF0-LN7-1134BL, NBF0-LN8-1194BR, NBF0-LN8-1198AR, NBF0-LN8-1205BL, NBF0-LN9-1315BL and NBF0-LN9-1358IR—were provided…
Microbiome Weak Spot of Metastatic Melanoma Cells IdentifiedBy adminNovember 6, 20250 Credit: Christoph Burgstedt/Getty Images A study published today in Nature reveals a unique weakness of metastatic melanoma cells that have…
Microbiome “Craters” on Melanoma Tumors Unveil Biomarker of Immunotherapy SuccessBy adminOctober 18, 20250 Credit: National Institutes of Health/Stocktrek Images/Getty Images A study published today in Cell has revealed the existence of “craters” on…
